Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2005
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272751 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005US20050272733 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272701 Pharmaceutical composition
12/08/2005US20050272666 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/08/2005US20050272658 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP)
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272036 Ketones
12/08/2005US20050269722 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
12/08/2005CA2848881A1 Treatment of depressive disorders
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2567703A1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
12/08/2005CA2567397A1 Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective
12/08/2005CA2566362A1 Treating seizures using ice inhibitors
12/08/2005CA2566154A1 Combination of atomoxetine and a 5t1a receptor agonist for treating adhd and other disorders
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2565098A1 Treatment of neurodegenerative disease through intracranial delivery of sirna
12/08/2005CA2562243A1 Treatment of polychondritis and mononeuritis multiplex with anti-cd20 antibodies
12/08/2005CA2562035A1 Treatment of depressive disorders
12/08/2005CA2509265A1 Methods of delaying alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and hmg coa reductase inhibitor
12/07/2005EP1602666A1 Novel protein and its dna
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602657A2 Substituted 9-alkyladenines
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602645A1 Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602374A1 Remedy for drug/substance dependence
12/07/2005EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1602367A1 Transdermal delivery system for treatment of cognitive disorders
12/07/2005EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
12/07/2005EP1601674A2 Hydroxy alkyl substituted 1,3,8-triazaspiro 4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
12/07/2005EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
12/07/2005EP1601363A2 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
12/07/2005EP1601358A1 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
12/07/2005EP1601349A1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament
12/07/2005EP1525198B1 Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
12/07/2005EP1501823B1 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1362593B1 Cytidine-phosphocholine for the treatment of diabetic neuropathy
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1290451B1 Diagnosis of alzheimer's disease using ldl receptor protein-1
12/07/2005EP1252323B1 Virus strains for the oncolytic treatment of cancer
12/07/2005EP1230551B1 Methods to identify compounds that modulate neuronal activity
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1212056B1 Methods and compositions for bisubstrate inhibitors of acetyltransferases
12/07/2005EP1196129B1 Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1165118B1 Treatment of multiple sclerosis with a combination of interferon and growth hormone
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1109579B1 Use of tgf-beta inhibitors for treating cerebral disorders
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005EP0831812B1 Methods and compositions for stimulating neurite growth
12/07/2005EP0724589B1 A method for enhancing neurone survival and agents useful for same
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1705663A Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
12/07/2005CN1705660A New dihydro-4(1h)-pyridinone derivatives are useful in the treatment of cognitive disorders, neurodegenerative diseases and pain
12/07/2005CN1705654A Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram
12/07/2005CN1705653A 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
12/07/2005CN1705644A Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/07/2005CN1705480A 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity
12/07/2005CN1705476A Enhancement of alcohol metabolism
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230436C Imidazo[1,5,-a] pyrimido[5,4-d]benzazepine derivatives as GABAA receptor modulators
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors
12/07/2005CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230202C External coated chewing gum products
12/07/2005CN1230176C Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-D] pyrimidine for treatment of pain
12/07/2005CN1230174C Selective iGLuR5 receptor antagonists for the treatment of migraine
12/07/2005CN1230173C Preventives and remedies for complications of diabetes
12/07/2005CN1230172C Blood circulation improving agent
12/07/2005CN1230168C Agent with an antidepressive effect
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/07/2005CN1230164C Combinations of(S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxion[2,3-e]indol-8-one and neuroleptics
12/07/2005CN1230161C Persimmon leaf extract and its preparation and its usage
12/07/2005CN1230157C Application of saccinic acid in preparing antianxiety medicine
12/07/2005CN1230150C Slow release pharmaceutical compositions comprising lithium carbonate
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972318 Complex of a chaperone protein with amyloid
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
1 ... 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 ... 1833